Dr. Zheng graduated from Zhejiang University School of Medicine with M.D. and King’s College, University of London with Ph.D. in Immunology.
He previously taught in the University of Maryland School of Medicine and Duke University Medical Center.
He is also a Tenured Professor in the Department of Pathology and Immunology, Baylor College of Medicine.
Dr. Zheng has strong research expertise and achievements in immunology.
He led early discovery for autoimmune diseases in GSK, and served as Global Vice President of Immunology Therapeutic Area in Johnson & Johnson.
George L. MacGregor Distinguished Chair in Biomedical Science, director of Inflammation Research Center, Professor in the Department of Molecular Biology at the University of Texas Southwestern Medical Center, and Investigator of the Howard Hughes Medical Institute
Recipient of the 2020 William B. Coley Award, winner of the 2019 Breakthrough Prize in Life Sciences, Winner of the 2018 Lurie Prize in Biomedical Sciences, the 2012 recipient of the National Academy of Sciences Award in Molecular Biology
Chen is one of the pioneers in the field of natural immunity and the discoverer of cGAS, cGAMP, MAVS and other important natural immunity molecules.
Chen’s research into complex cellular biochemistry has led to the discovery of pathways and proteins that trigger immune and stress responses.
Associate Professor, Department of Pathology and Laboratory Medicine, University of Pennsylvania
Previously responsible for the product/process development of Kymriah, the world’s first CAR-T cell therapy approved by FDA
Early inventor and pioneer in CAR-T cell therapy
In-depth experience in immunology and immunotherapy, approaches to improving the anti-tumor efficacy of gene-engineered T cells for the treatment of cancers
Over 10 years of working experience in the National Institutes of Health (NIH)
Member of Chinese Academy of Sciences
Director and Professor, Institute for Immunology, Tsinghua University
Fellow of the American Association for the Advancement of Science
The 2009 American Society of Immunologists-BD Biosciences Investigator Award, the 2019 International Cytokine and Interferon Society Biolegend-William E. Paul Award
Specialty Chief Editor for Frontiers in Immunology, T Cell Biology, Associate Chief Editor for China Science Life Sciences, and Editorial Board Member of Immunity
Published more than 200 papers in immunology field, and was recognized as a “Highly Cited Scientist” in the world for seven consecutive years from 2014 to 2020
Chair and Professor, Department of Hematologic Malignancies Translational Science; Director, Gehr Family Center for Leukemia Research; Professor, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope
Former Professor of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, and Pharmaceutics Division Hematology, Comprehensive Cancer Center and The Ohio State University
Member of the editorial board for several journals; published more than 270 peer-reviewed articles and research papers
Professor of Medicine in Tsinghua University (TU) and Second Military Medical University (SMMU)
Founder Executive Dean of School of Clinical Medicine, TU and Vice President of Beijing Tsinghua Changgung Hospital, TU
Founder chair for the Department of Rheumatology and Immunology at Shanghai Changzheng hospital
Vice-President of Chinese Rheumatology Association, former Vice-President of Chinese Rheumatologist and Immunologist Association, former President of Shanghai Rheumatology Association, former R.D. Wright fellow of Australian National Health & Medical Research Council and Professor in UQ
Publications in Nature, Nature Genetics, Arthritis & Rheumatism, Annals of Rheumatic Diseases, lancet Rheumatology, The Journal of Immunology, Proc Natl Acad Sci USA, The Journal of Experimental Medicine, and Annual Review of Immunology